Medication info
Nellastone 10 mg (Rosuvastatin Calcium)

Nellastone 10 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
HanKook Nelson Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202003216 · Approved 2020.04.29 · Insurance code 656702100

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; the dose may be adjusted as a maintenance dose if a greater reduction in LDL cholesterol is needed. A maintenance dose of 10 milligrams once daily achieves control in most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses above 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
HanKook Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is primarily used for various types of dyslipidemia related to hypercholesterolemia. It is used as an adjunctive therapy when dietary changes and exercise alone are insufficient for managing primary hypercholesterolemia and mixed dyslipidemia patients. It also helps reduce cholesterol levels when used in conjunction with dietary changes or other lipid-lowering therapies in patients with familial hypercholesterolemia. In particular, it is administered as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia to reduce cholesterol and apolipoprotein B levels. It also acts to complement dietary therapy in patients with primary dysbetalipoproteinemia. This medication lowers total cholesterol and LDL cholesterol levels, delays the progression of atherosclerosis, and improves health by reducing the risk of stroke, myocardial infarction, and vascular revascularization procedures in adults at high risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; the dose may be adjusted as a maintenance dose if a greater reduction in LDL cholesterol is needed. A maintenance dose of 10 milligrams once daily achieves control in most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses above 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to this medication, those with liver problems, individuals with muscle disorders, those with severe renal impairment, and pregnant or breastfeeding women should not take this medication. Additionally, caution is necessary for patients at a higher risk of muscle-related side effects or those taking certain medications. This medication may affect liver function, so patients with a history of liver disease or those who consume alcohol excessively should undergo liver function tests before taking it and should have regular liver function monitoring during treatment. Muscle-related symptoms such as myalgia, myopathy, and rhabdomyolysis can occur, so patients experiencing symptoms like muscle pain, muscle weakness, or cramps should inform their doctor immediately. If blood tests show elevated indicators of muscle damage, the medication may need to be discontinued. The effects and risks of side effects from this medication can vary according to specific genetic factors, so dose adjustments may be necessary based on the patient's condition. Furthermore, this medication may interact with other drugs; therefore, patients should inform their doctor or pharmacist of any other medications they are currently taking, as co-administration with certain drugs can increase the blood concentration of this medication and raise the risk of side effects. Women who may become pregnant should ensure the use of appropriate contraception, and this medication should not be used during pregnancy or while breastfeeding. In cases of overdose, there is no specific antidote, so treatment should be symptomatic, and monitoring of liver function and muscle damage is essential. Lastly, this medication can rarely cause severe skin reactions, liver damage, kidney problems, and neurological complications, so patients should contact medical personnel immediately if any unusual symptoms occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myopathy, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.